Histone Chaperone SSRP1 is Essential for Wnt Signaling Pathway Activity During Osteoblast Differentiation

Stem Cells

Volumn 34, Issue 5, 2016, Pages 1369-1376

  Hossan, Tareq ^a   Nagarajan, Sankari ^a   Baumgart, Simon J ^a   Xie, Wanhua ^a   Magallanes, Roberto Tirado ^b   Hernandez, Céline ^b   Chiaroni, Pierre Marie ^b   Indenbirken, Daniela ^c   Spitzner, Melanie ^a   Thomas Chollier, Morgane ^b   Grade, Marian ^a   Thieffry, Denis ^b   Grundhoff, Adam ^c   Wegwitz, Florian ^a   Johnsen, Steven A ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b PSL RESEARCH UNIVERSITY   (France)

^c LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

Author keywords

Histone chaperone; Osteoblast differentiation; Structure specific recognition protein; Wnt signaling

Indexed keywords

ALPL PROTEIN; BETA CATENIN; BGLAP PROTEIN; BONE MORPHOGENETIC PROTEIN 4; CHAPERONE; DICKKOPF 1 PROTEIN; LRP4 PROTEIN; LYMPHOID ENHANCER FACTOR 1; PEPTIDES AND PROTEINS; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PYRUVATE DEHYDROGENASE KINASE 4; RASD1 PROTEIN; SECRETED FRIZZLED RELATED PROTEIN 2; STRUCTURE SPECIFIC RECOGNITION PROTEIN 1; TRANSCRIPTION FACTOR 7 LIKE 2; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTOME; UNCLASSIFIED DRUG; WNT PROTEIN; WNT11 PROTEIN; WNT2 PROTEIN; DNA BINDING PROTEIN; HIGH MOBILITY GROUP PROTEIN; SSRP1 PROTEIN, HUMAN; TRANSCRIPTION ELONGATION FACTOR;

ADIPOCYTE; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; DOWN REGULATION; FETUS; GENE EXPRESSION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; OSTEOBLAST; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RNA SEQUENCE; WNT SIGNALING PATHWAY; CELL LINE; CELL NUCLEUS; CYTOLOGY; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PROTEIN TRANSPORT; REPRODUCIBILITY; WNT SIGNALING;

ADIPOCYTES; BETA CATENIN; CELL DIFFERENTIATION; CELL LINE; CELL NUCLEUS; DNA-BINDING PROTEINS; GENE DELETION; GENE EXPRESSION REGULATION; HIGH MOBILITY GROUP PROTEINS; HISTONE CHAPERONES; HUMANS; MESENCHYMAL STROMAL CELLS; OSTEOBLASTS; PROTEIN TRANSPORT; REPRODUCIBILITY OF RESULTS; TRANSCRIPTIONAL ELONGATION FACTORS; WNT SIGNALING PATHWAY;

EID: 84964988492     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.2287     Document Type: Article

References (39)

1. Häkelien A-M, Bryne JC, Harstad KG, et al., The regulatory landscape of osteogenic differentiation. Stem Cells 2014; 32: 2780-2793.
2. Rodan GA, Martin TJ,. Therapeutic approaches to bone diseases. Science 2000; 289: 1508-1514.
3. Karpiuk O, Najafova Z, Kramer F, et al., The histone H2B monoubiquitination regulatory pathway is required for differentiation of multipotent stem cells. Mol Cell 2012; 46: 705-713.
4. Gordon JAR, Stein JL, Westendorf JJ, et al., Chromatin modifiers and histone modifications in bone formation, regeneration, and therapeutic intervention for bone-related disease. Bone 2015; 81: 739-745.
5. Wei Y, Chen Y-H, Li L-Y, et al., CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells. Nat Cell Biol 2011; 13: 87-94.
6. Hemming S, Cakouros D, Isenmann S, et al., EZH2 and KDM6A act as an epigenetic switch to regulate mesenchymal stem cell lineage specification. Stem Cells 2014; 32: 802-815.
7. Avvakumov N, Nourani A, Côté J,. Histone chaperones: Modulators of chromatin marks. Mol Cell 2011; 41: 502-514.
8. Orphanides G, Wu WH, Lane WS, et al., The chromatin-specific transcription elongation factor FACT comprises human SPT16 and SSRP1 proteins. Nature 1999; 400: 284-288.
9. Formosa T,. The role of FACT in making and breaking nucleosomes. Biochim Biophys Acta 2012; 1819: 247-255.
10. Kumari A, Mazina OM, Shinde U, et al., A role for SSRP1 in recombination-mediated DNA damage response. J Cell Biochem 2009; 108: 508-518.
11. Kari V, Shchebet A, Neumann H, et al., The H2B ubiquitin ligase RNF40 cooperates with SUPT16H to induce dynamic changes in chromatin structure during DNA double-strand break repair. Cell Cycle 2011; 10: 3495-3504.
12. Heo K, Kim H, Choi SH, et al., FACT-mediated exchange of histone variant H2AX regulated by phosphorylation of H2AX and ADP-ribosylation of Spt16. Mol Cell 2008; 30: 86-97.
13. Garcia H, Fleyshman D, Kolesnikova K, et al., Expression of FACT in mammalian tissues suggests its role in maintaining of undifferentiated state of cells. Oncotarget 2011; 2: 783-796.
14. Garcia H, Miecznikowski JC, Safina A, et al., Facilitates chromatin transcription complex is an "accelerator" of tumor transformation and potential marker and target of aggressive cancers. Cell Rep 2013; 4: 159-173.
15. Pavri R, Zhu B, Li G, et al., Histone H2B monoubiquitination functions cooperatively with FACT to regulate elongation by RNA polymerase II. Cell 2006; 125: 703-717.
16. Prenzel T, Begus-Nahrmann Y, Kramer F, et al., Estrogen-dependent gene transcription in human breast cancer cells relies upon proteasome-dependent monoubiquitination of histone H2B. Cancer Res 2011; 71: 5739-5753.
17. Simonsen JL, Rosada C, Serakinci N, et al., Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol 2002; 20: 592-596.
18. Harris SA, Enger RJ, Riggs BL, et al., Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res 1995; 10: 178-186.
19. Nagarajan S, Hossan T, Alawi M, et al., Bromodomain protein BRD4 is required for estrogen receptor-dependent enhancer activation and gene transcription. Cell Rep 2014; 8: 460-469.
20. Bedi U, Scheel AH, Hennion M, et al., SUPT6H controls estrogen receptor activity and cellular differentiation by multiple epigenomic mechanisms. Oncogene 2015; 34: 465-473.
21. Takahashi N, Yamana H, Yoshiki S, et al., Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology 1988; 122: 1373-1382.
22. Anders S, Huber W,. Differential expression analysis for sequence count data. Genome Biol 2010; 11: R106.
23. Huang DW, Sherman BT, Lempicki RA,. Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nature Protoc 2009; 4: 44-57.
24. Huang DW, Sherman BT, Lempicki RA,. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009; 37: 1-13.
25. Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M,. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res 2016; 44: D457-D462.
26. Kanehisa M, Sato Y,. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 2000; 28: 27-30.
27. Kandasamy K, Mohan SS, et al., NetPath: A public resource of curated signal transduction pathways. Genome Biology 2010; 11: R3.
28. Funahashi A, Tanimura N, Morohashi M, Kitano H,. CellDesigner: a process diagram editor for gene-regulatory and biochemical networks. BIOSILICO 2003; 1: 159 -162.
29. Funahashi A, Matsuoka, Y, Jouraku, A, Morohashi M, Kitano H,. CellDesigner 3.5: A Versatile Modeling Tool for Biochemical Networks. Proceedings of the IEEE 2008; 96: 1254 -1265.
30. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T., Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Research 2003; 13: 2498 -504.
31. Veeman MT, Slusarski DC, Kaykas A, et al., Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements. Curr Biol 2003; 13: 680-685.
32. Kendziorra E, Ahlborn K, Spitzner M, et al., Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapy. Carcinogenesis 2011; 32: 1824-1831.
33. Dyer BW, Ferrer FA, Klinedinst DK, et al., A noncommercial dual luciferase enzyme assay system for reporter gene analysis. Anal Biochem 2000; 282 (1): 158-161.
34. Baron R, Kneissel M,. WNT signaling in bone homeostasis and disease: From human mutations to treatments. Nat Med 2013; 19: 179-192.
35. Sánchez-Duffhues G, Hiepen C, Knaus P, et al., Bone morphogenetic protein signaling in bone homeostasis. Bone 2015; 80: 43-59.
36. Lin GL, Hankenson KD,. Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation. J Cell Biochem 2011; 112: 3491-3501.
37. Zhang R, Oyajobi BO, Harris SE, et al., Wnt/β-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts. Bone 2013; 52: 145-156.
38. Kang S, Bennett CN, Gerin I, et al., Wnt signaling stimulates osteoblastogenesis of mesenchymal precursors by suppressing CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma. J Biol Chem 2007; 282: 14515-14524.
39. Clevers H, Nusse R,. Wnt/β-catenin signaling and disease. Cell 2012; 149: 1192-1205.